Merck Serono
Merck Serono asks EMEA to re-think Erbitux rejection
July 30, 2009Research and Development, Sales and Marketing Cancer, EMEA, Erbitux, Europe, Merck Serono
Merck Serono is to appeal against the European rejection of Erbitux as a lung cancer treatment.Erbitux has been rejected as …
Working Life: Kevin Crowe
June 23, 2009Sales and Marketing Merck Serono, WL, sales force effectiveness
How did you find your way into your current role?I have worked for several years in the Canadian pharmaceutical industry …
Merck Serono breast cancer vaccine enters phase III
June 22, 2009Research and Development Cancer, Merck Serono, Stimuvax, vaccines
Merck Serono is to begin a global phase III study for its therapeutic cancer vaccine Stimuvax in patients with advanced, …
Recession hits Merck KGaA profits
April 29, 2009Sales and Marketing Merck Serono
Merck KGaA saw its profits fell through the floor for the first quarter this year due to a combination of …
Merck Serono launches Kuvan in Europe
April 24, 2009Sales and Marketing Kuvan, Merck Serono, PKU
Kuvan, the first treatment for two rare neurological disorders, has been launched in the UK, France and Germany.Merck Serono’s drug …
Merck Serono sets up biotech fund
March 24, 2009Research and Development Merck Serono, biotech
Merck Serono has set up a venture capital fund to invest in emerging biotech companies working in its core therapy …
Merck Serono’s multiple sclerosis drug on track for filing
January 23, 2009Research and Development, Sales and Marketing MS, Merck Serono
Cladribine, a new oral treatment for multiple sclerosis is on track for a mid-2009 filing after the release of encouraging …
The Pharmafocus Interview: Elmar Schnee
January 6, 2009Sales and Marketing EU, Germany, IQWIG, Merck Serono, cost-effectiveness
Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …
Merck Serono takes lead role in antibody partnership
September 11, 2008Research and Development Merck Serono
Merck Serono has agreed to take on full responsibility for developing a promising antibody from its partner ZymoGenetics. The German …
Erbitux set for first line treatment of colorectal cancer
June 5, 2008Sales and Marketing Cancer, Merck Serono
Merck Serono's Erbitux looks set for approval in Europe as a first-line colon cancer treatment. Approved four years ago as …
Merck to buy Serono for $13 billion
September 22, 2006Sales and Marketing Merck Serono
German pharma company Merck is to acquire Serono for $13.5 billion, creating one of Europes largest bio-pharmaceutical technology companies.The new …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
